Intriguing results were provided by study of Liu et al., which has shown that the typical OI type V pathogenic variant c.-14C > T in the IFITM5 gene promoted apoptosis in osteosarcoma cells, inhibited tumor invasion, and promoted osteogenic differentiation [43]. This evidence concerns the gene IFITM5 and osteogenesis imperfecta type 5.